SPHK1 and pancreatic neoplasm: We propose that the selective pressure to maintain rapid growth and apoptotic resistance promotes this shift in SK1-mediated S1P/C16 Cer metabolism because it is a significant component of metabolic reprogramming in human pancreatic cancer cells.